GlassScriptPhysician profile
Genoveva N Prisacaru
NPI 1740325133
$1,491.13
in general payments reported to CMS, 2019-2025
19 companies · $275 in 2025
The $275 reported for 2025 was more than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $59.45 · 2020: $520 · 2021: $62.79 · 2022: $289 · 2023: $144 · 2024: $142 · 2025: $275.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $497 · Education: $63.35.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $496.87 |
| Education | $63.35 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $519.72 | 2020 | |
| Dysis Medical, INC. | $270.24 | 2021-2022 | |
| Hologic Sales and Service, LLC | $171.86 | 2024-2025 | Aptima, Thinprep 2000 Processor |
| Mayne Pharma Commercial LLC | $85.09 | 2025 | |
| Currax Pharmaceuticals LLC | $80.85 | 2023-2025 | Nexletol, Contrave |
| Avanos Medical | $55.51 | 2019-2022 | |
| Meditrina | $47.86 | 2021 | |
| Astellas Pharma US INC | $32.55 | 2023-2024 | Veozah |
| Millicent US INC | $30.09 | 2024-2025 | Intrarosa |
| Evofem Biosciences, INC. | $23.01 | 2023 | Phexxi |
| Coopersurgical, INC. | $22.22 | 2023 | Wallach Cryosurgical Equipment |
| Shield Therapeutics INC | $21.38 | 2025 | |
| Agile Therapeutics, INC. | $21.17 | 2022 | |
| Exact Sciences Corporation | $20.58 | 2025 | The Cologuard Plus Collection Kit |
| Abbvie INC. | $20.02 | 2023 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $19.82 | 2025 | |
| Minerva Surgical, INC | $17.59 | 2025 | |
| Olympus America INC. | $16.41 | 2019 | |
| Becton, Dickinson and Company | $15.16 | 2023 | Bd Max System, Bd Max Instrument |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Genoveva Prisacaru listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.